{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:52:33Z","timestamp":1787496753143,"version":"build-2736575974"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1093\/jac\/dkx300","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T07:07:17Z","timestamp":1501225637000},"page":"3425-3434","source":"Crossref","is-referenced-by-count":17,"title":["Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen"],"prefix":"10.1093","volume":"72","author":[{"given":"Fran\u00e7ois","family":"Raffi","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, University Hospital of Nantes, Nantes, France"},{"name":"INSERM CIC 1413, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Hanf","sequence":"additional","affiliation":[{"name":"INSERM CIC 1413, Nantes University Hospital, Nantes, France"},{"name":"INSERM UMR 1181 B2PHI, Versailles Saint Quentin University, Institut Pasteur, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ferry","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Diseases Department, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Khatchatourian","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, University Hospital of Nantes, Nantes, France"},{"name":"INSERM CIC 1413, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Joly","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, H\u00f4pital Bichat, AP-HP, Paris, France"},{"name":"National Institute of Health and Medical Research (INSERM) IAME, UMR 1137, Paris Diderot University, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pugliese","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Centre Hospitalier Universitaire de l'Archet, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Katlama","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Assistance publique-H\u00f4pitaux de Paris, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France"},{"name":"Institut Pierre-Louis d'Epid\u00e9miologie et de Sant\u00e9 Publique, Unit\u00e9 Mixte de Recherche en Sant\u00e9 1136, Inserm, Paris and Universit\u00e9 Pierre et Marie Curie Paris 06, Sorbonne Universit\u00e9s, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Robineau","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Gustave Dron Hospital, Tourcoing, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chirouze","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, University Hospital of Besan\u00e7on, UMR CNRS 6249, University of Bourgogne-Franche Comt\u00e9, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jacomet","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, University of Clermont-Ferrand, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Delobel","sequence":"additional","affiliation":[{"name":"INSERM, UMR1043, Toulouse and Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France"},{"name":"Service des Maladies Infectieuses et Tropicales, CHU de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Poizot-Martin","sequence":"additional","affiliation":[{"name":"Aix-Marseille University, APHM H\u00f4pital Sainte-Marguerite, Immuno-Hematology Clinic, Marseille, France"},{"name":"Inserm U912 (SESSTIM), Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ravaux","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aix-Marseille University, APHM, H\u00f4pital de La Conception, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[{"name":"AP-HP-Necker Hospital, Infectious Diseases Department, Necker-Pasteur Infectiology Centre, Paris, France"},{"name":"Medical Centre of Pasteur Institut, Necker-Pasteur Infectiology Centre, Paris, France"},{"name":"EA7327, Paris Descartes University, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Gagneux-Brunon","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, University of Saint-Etienne, Saint-Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rey","sequence":"additional","affiliation":[{"name":"Centre for HIV Infection Care, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Reynes","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, UMI233 INSERM U1175, Montpellier University Hospital, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"May","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital Centre, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firouz\u00e9","family":"Bani-Sadr","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Infectious Diseases, and Clinical Immunology Reims Teaching Hospitals, University of Reims, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Hoen","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Hyacinthe Bastaraud, Universit\u00e9 des Antilles, Service de Maladies Infectieuses et Tropicales, Dermatologie, M\u00e9decine Interne, Point-\u00e1-Pitre, France"},{"name":"Inserm CIC 1424, Centre Hospitalier Universitaire de Pointe-\u00e0-Pitre, Pointe-\u00e0-Pitre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Morrier","sequence":"additional","affiliation":[{"name":"Departement of Infectious Diseases, CHD Vendee, La Roche sur yon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Cabie","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, University Hospital of Martinique, Fort-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"Allavena","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, University Hospital of Nantes, Nantes, France"},{"name":"INSERM CIC 1413, Nantes University Hospital, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Dat\u2019AIDS Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"key\n\t\t\t\t20180328155117_dkx300-B1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/cid\/ciu834","article-title":"Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access","volume":"60","author":"Delaugerre","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/QAI.0b013e3181da1287","article-title":"Raltegravir versus efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses","volume":"55","author":"Lennox","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QAI.0b013e318286415c","article-title":"A randomized, double-blind comparison of coformulated elvitegravir\/cobicistat\/emtricitabine\/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results","volume":"62","author":"Rockstroh","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M14-1084","article-title":"Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial","volume":"161","author":"Lennox","year":"2014","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.286.20.2560","article-title":"HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load","volume":"286","author":"Phillips","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-1293.2009.00719.x","article-title":"A large French prospective cohort of HIV-infected patients: the Nadis Cohort","volume":"10","author":"Pugliese","year":"2009","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B8","author":"R Core Team","year":"2015"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/QAD.0000000000000519","article-title":"Dolutegravir efficacy at 48\u2009weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials","volume":"29","author":"Raffi","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel","volume":"316","author":"G\u00fcnthard","year":"2016","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archinte.160.8.1123","article-title":"Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study","volume":"160","author":"Paredes","year":"2000","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/QAD.0b013e32833847af","article-title":"Long-term trends in adherence to antiretroviral therapy from start of HAART","volume":"24","author":"Cambiano","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/aid.2015.0296","article-title":"Younger age predicts failure to achieve viral suppression and virologic rebound among HIV-1-infected persons in serodiscordant partnerships","volume":"32","author":"Mujugira","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B14","author":"Department of Health and Human Services","year":"2016"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B15","author":"European AIDS Clinical Society","year":"2016"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/135965350801300707","article-title":"Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy","volume":"13","author":"Geretti","year":"2008","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cit529","article-title":"Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12\u2009years of observation","volume":"57","author":"Laprise","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/QAD.0000000000000544","article-title":"Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients","volume":"29","author":"Vandenhende","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B19","doi-asserted-by":"crossref","first-page":"ofw089.","DOI":"10.1093\/ofid\/ofw089","article-title":"A single quantifiable viral load is predictive of virological failure in human immunodeficiency virus (HIV)-infected patients on combination antiretroviral therapy: the Austrian HIV Cohort Study","volume":"3","author":"Leierer","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B20","doi-asserted-by":"crossref","first-page":"ofu119.","DOI":"10.1093\/ofid\/ofu119","article-title":"Antiretroviral regimen and suboptimal medication adherence are associated with low-level human immunodeficiency virus viremia","volume":"2","author":"Konstantopoulos","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1468-1293.2012.00989.x","article-title":"The MONET trial: week 144 analysis of the efficacy of darunavir\/ritonavir (DRV\/r) monotherapy versus DRV\/r plus two nucleoside reverse transcriptase inhibitors, for patients with viral load <50 HIV-1 RNA copies\/mL at baseline","volume":"13","author":"Arribas","year":"2012","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B22","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1086\/590943","article-title":"Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials","volume":"47","author":"Gupta","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/infdis\/jir353","article-title":"Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy","volume":"204","author":"Taiwo","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B24","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/jac\/dks254","article-title":"Risk factors for raltegravir resistance development in clinical practice","volume":"67","author":"Malet","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CMR.00015-16","article-title":"Total HIV-1 DNA, a marker of viral reservoir dynamics with clinical implications","volume":"29","author":"Avettand-F\u00e8no\u00ebl","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180328155117_dkx300-B26","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/cid\/cit125","article-title":"Clinical implications of HIV-1 minority variants","volume":"56","author":"Li","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/12\/3425\/21899125\/dkx300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T11:41:08Z","timestamp":1659267668000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/72\/12\/3425\/4106332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,9,6]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx300","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12]]},"published":{"date-parts":[[2017,9,6]]}}}